Suzhou Connect Biopharmaceuticals   Report issue

For profit Phase 1 Phase 2
Founded: Taicang China (2012)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2014
NCT02280434
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Connect Biopharma Australia Pty Ltd | Suzhou Connect Biopharmaceuticals, Ltd.